These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10757815)

  • 1. Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent.
    Müller C; Readhead C; Diederichs S; Idos G; Yang R; Tidow N; Serve H; Berdel WE; Koeffler HP
    Mol Cell Biol; 2000 May; 20(9):3316-29. PubMed ID: 10757815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of the genomic methylation status of the human cyclin A1 promoter by a novel real-time PCR-based methodology.
    Müller-Tidow C; Bornemann C; Diederichs S; Westermann A; Klümpen S; Zuo P; Wang W; Berdel WE; Serve H
    FEBS Lett; 2001 Feb; 490(1-2):75-8. PubMed ID: 11172814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
    Koizume S; Tachibana K; Sekiya T; Hirohashi S; Shiraishi M
    Nucleic Acids Res; 2002 Nov; 30(21):4770-80. PubMed ID: 12409468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successive increases in human cyclin A1 promoter activity during spermatogenesis in transgenic mice.
    Müller-Tidow C; Readhead C; Cohen AH; Asotra K; Idos G; Diederichs S; Cauvet T; Yang R; Berdel WE; Serve H; Koeffler HP
    Int J Mol Med; 2003 Mar; 11(3):311-5. PubMed ID: 12579332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
    J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
    Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM
    Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.
    El-Osta A; Kantharidis P; Zalcberg JR; Wolffe AP
    Mol Cell Biol; 2002 Mar; 22(6):1844-57. PubMed ID: 11865062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells.
    Magdinier F; Billard LM; Wittmann G; Frappart L; Benchaïb M; Lenoir GM; Guérin JF; Dante R
    FASEB J; 2000 Aug; 14(11):1585-94. PubMed ID: 10928993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins.
    Majumder S; Kutay H; Datta J; Summers D; Jacob ST; Ghoshal K
    J Cell Biochem; 2006 Apr; 97(6):1300-16. PubMed ID: 16329111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
    Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of the mouse H-rev107 gene encoding a class II tumor suppressor by CpG methylation.
    Roder K; Latasa MJ; Sul HS
    J Biol Chem; 2002 Aug; 277(34):30543-50. PubMed ID: 12055182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated.
    Kudo S
    Mol Cell Biol; 1998 Sep; 18(9):5492-9. PubMed ID: 9710633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
    Müller I; Wischnewski F; Pantel K; Schwarzenbach H
    BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C; Song JZ; Davidson B; Clark SJ
    Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor.
    Jiang CL; Jin SG; Lee DH; Lan ZJ; Xu X; O'Connor TR; Szabó PE; Mann JR; Cooney AJ; Pfeifer GP
    Genomics; 2002 Dec; 80(6):621-9. PubMed ID: 12504854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.
    Danam RP; Howell SR; Brent TP; Harris LC
    Mol Cancer Ther; 2005 Jan; 4(1):61-9. PubMed ID: 15657354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter.
    De Smet C; Lurquin C; Lethé B; Martelange V; Boon T
    Mol Cell Biol; 1999 Nov; 19(11):7327-35. PubMed ID: 10523621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.